{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:52:44Z","timestamp":1791395564407,"version":"4.3.3"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32201237"],"award-info":[{"award-number":["32201237"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific and technological projects of Henan province","award":["222102310270"],"award-info":[{"award-number":["222102310270"]}]},{"name":"Henan medical science and technology program","award":["LHGJ20220767"],"award-info":[{"award-number":["LHGJ20220767"]}]},{"name":"Henan International Joint Laboratory for Prevention and Treatment of Pediatric Disease foundation","award":["EKB202204"],"award-info":[{"award-number":["EKB202204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71211-x","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T04:02:33Z","timestamp":1724990553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Joint metabolomics and transcriptomics analysis systematically reveal the impact of MYCN in neuroblastoma"],"prefix":"10.1038","volume":"14","author":[{"given":"Bang","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qionglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wancun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"71211_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/pbc.25784","volume":"63","author":"P Beaudry","year":"2016","unstructured":"Beaudry, P. et al. A pilot study on the utility of serum metabolomics in neuroblastoma patients and xenograft models. Pediatr. Blood Cancer 63, 214\u2013220 (2016).","journal-title":"Pediatr. Blood Cancer"},{"key":"71211_CR2","doi-asserted-by":"publisher","first-page":"1114295","DOI":"10.3389\/fphar.2023.1114295","volume":"14","author":"X Zhou","year":"2023","unstructured":"Zhou, X. et al. Therapy resistance in neuroblastoma: Mechanisms and reversal strategies. Front. Pharmacol. 14, 1114295 (2023).","journal-title":"Front. Pharmacol."},{"key":"71211_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/pan.14673","volume":"33","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. Perioperative hypertension and anesthetic management in patients undergoing resection of neuroblastoma. Paediatr. Anaesth. 33, 577\u2013582 (2023).","journal-title":"Paediatr. Anaesth."},{"key":"71211_CR4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s11912-022-01270-8","volume":"24","author":"KI Lundberg","year":"2022","unstructured":"Lundberg, K. I., Treis, D. & Johnsen, J. I. Neuroblastoma heterogeneity, plasticity, and emerging therapies. Curr. Oncol. Rep. 24, 1053\u20131062 (2022).","journal-title":"Curr. Oncol. Rep."},{"key":"71211_CR5","doi-asserted-by":"publisher","first-page":"eadg6693","DOI":"10.1126\/sciadv.adg6693","volume":"9","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. A Mycn-independent mechanism mediating secretome reprogramming and metastasis in Mycn-amplified neuroblastoma. Sci. Adv. 9, eadg6693 (2023).","journal-title":"Sci. Adv."},{"key":"71211_CR6","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1200\/JCO.21.00278","volume":"39","author":"MS Irwin","year":"2021","unstructured":"Irwin, M. S. et al. Revised neuroblastoma risk classification system: A report from the children\u2019s oncology group. J. Clin. Oncol. 39, 3229\u20133241 (2021).","journal-title":"J. Clin. Oncol."},{"key":"71211_CR7","doi-asserted-by":"publisher","first-page":"e27257","DOI":"10.1002\/pbc.27257","volume":"65","author":"JW Lee","year":"2018","unstructured":"Lee, J. W. et al. Clinical significance of Mycn amplification in patients with high-risk neuroblastoma. Pediatr. Blood Cancer. 65, e27257 (2018).","journal-title":"Pediatr. Blood Cancer."},{"key":"71211_CR8","doi-asserted-by":"publisher","first-page":"e000129","DOI":"10.1136\/wjps-2020-000129","volume":"3","author":"C Chui","year":"2020","unstructured":"Chui, C. Effects of preoperative chemotherapy on neuroblastoma with Mycn amplification: A surgeon\u2019s perspective. World J. Pediatr. Surg. 3, e000129 (2020).","journal-title":"World J. Pediatr. Surg."},{"key":"71211_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1158\/2159-8290.CD-17-0273","volume":"8","author":"DS Rickman","year":"2018","unstructured":"Rickman, D. S., Schulte, J. H. & Eilers, M. The expanding world of N-Myc\u2013driven tumors. Cancer Discov. 8, 150\u2013163 (2018).","journal-title":"Cancer Discov."},{"key":"71211_CR10","doi-asserted-by":"publisher","first-page":"624079","DOI":"10.3389\/fonc.2020.624079","volume":"10","author":"J Otte","year":"2021","unstructured":"Otte, J., Dyberg, C., Pepich, A. & Johnsen, J. I. Mycn function in neuroblastoma development. Front. Oncol. 10, 624079 (2021).","journal-title":"Front. Oncol."},{"key":"71211_CR11","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1158\/0008-5472.CAN-09-2598","volume":"70","author":"L Chen","year":"2010","unstructured":"Chen, L. et al. P53 is a direct transcriptional target of Mycn in neuroblastoma. Cancer Res. 70, 1377\u20131388 (2010).","journal-title":"Cancer Res."},{"key":"71211_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/path.4429","volume":"235","author":"P Ren","year":"2015","unstructured":"Ren, P. et al. Atf4 and N-Myc coordinate glutamine metabolism in Mycn-amplified neuroblastoma cells through Asct2 activation. J. Pathol. 235, 90\u2013100 (2015).","journal-title":"J. Pathol."},{"key":"71211_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.isci.2019.10.020","volume":"21","author":"G Oliynyk","year":"2019","unstructured":"Oliynyk, G. et al. Mycn-enhanced oxidative and glycolytic metabolism reveals vulnerabilities for targeting neuroblastoma. Iscience 21, 188\u2013204 (2019).","journal-title":"Iscience"},{"key":"71211_CR14","doi-asserted-by":"publisher","first-page":"7157","DOI":"10.1038\/s41598-020-64040-1","volume":"10","author":"B Tjaden","year":"2020","unstructured":"Tjaden, B. et al. N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma. Sci. Rep. 10, 7157 (2020).","journal-title":"Sci. Rep."},{"key":"71211_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.15698\/cst2022.02.264","volume":"6","author":"KV Floros","year":"2022","unstructured":"Floros, K. V. et al. Mycn upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in Mycn-amplified neuroblastoma. Cell Stress 6, 21\u201329 (2022).","journal-title":"Cell Stress"},{"key":"71211_CR16","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/ijc.33423","volume":"148","author":"B Arlt","year":"2021","unstructured":"Arlt, B. et al. Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against Mycn-amplified neuroblastoma. Int. J. Cancer 148, 1219\u20131232 (2021).","journal-title":"Int. J. Cancer"},{"key":"71211_CR17","doi-asserted-by":"publisher","first-page":"7504","DOI":"10.1038\/s41388-019-0967-3","volume":"38","author":"A Alptekin","year":"2019","unstructured":"Alptekin, A. et al. Glycine decarboxylase is a transcriptional target of Mycn required for neuroblastoma cell proliferation and tumorigenicity. Oncogene 38, 7504\u20137520 (2019).","journal-title":"Oncogene"},{"key":"71211_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/853916","volume":"2010","author":"V Costa","year":"2010","unstructured":"Costa, V., Angelini, C., De Feis, I. & Ciccodicola, A. Uncovering the complexity of transcriptomes with Rna-Seq. J. Biomed. Biotechnol. 2010, 1\u201319 (2010).","journal-title":"J. Biomed. Biotechnol."},{"key":"71211_CR19","doi-asserted-by":"publisher","first-page":"16991","DOI":"10.1038\/s41598-023-43988-w","volume":"13","author":"B Du","year":"2023","unstructured":"Du, B. et al. Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastoma. Sci. Rep. 13, 16991 (2023).","journal-title":"Sci. Rep."},{"key":"71211_CR20","first-page":"262","volume":"22","author":"X Fan","year":"2020","unstructured":"Fan, X. et al. A comprehensive analysis of potential prognostic biomarkers for Mycn-amplified neuroblastoma. Zhongguo Dang Dai Er Ke Za Zhi. 22, 262\u2013268 (2020).","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi."},{"key":"71211_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12920-020-00819-5","volume":"13","author":"E Lee","year":"2020","unstructured":"Lee, E. et al. Genomic profile of Mycn non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma. BMC Med. Genom. 13, 171 (2020).","journal-title":"BMC Med. Genom."},{"key":"71211_CR22","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1111\/cas.15555","volume":"113","author":"Y Shinno","year":"2022","unstructured":"Shinno, Y. et al. Polycomb Ezh1 regulates cell Cycle\/5-fluorouracil sensitivity of neuroblastoma cells in concert with Mycn. Cancer Sci. 113, 4193\u20134206 (2022).","journal-title":"Cancer Sci."},{"key":"71211_CR23","doi-asserted-by":"publisher","first-page":"H451","DOI":"10.1152\/ajpheart.00628.2021","volume":"322","author":"F Spyropoulos","year":"2022","unstructured":"Spyropoulos, F. et al. Metabolomic and transcriptomic signatures of chemogenetic heart failure. Am. J. Physiol. Heart Circul. Physiol. 322, H451\u2013H465 (2022).","journal-title":"Am. J. Physiol. Heart Circul. Physiol."},{"key":"71211_CR24","doi-asserted-by":"publisher","first-page":"793499","DOI":"10.3389\/fphar.2022.793499","volume":"13","author":"P Zhao","year":"2022","unstructured":"Zhao, P. et al. Integration of transcriptomics and metabolomics reveals the antitumor mechanism underlying tadalafil in colorectal cancer. Front. Pharmacol. 13, 793499 (2022).","journal-title":"Front. Pharmacol."},{"key":"71211_CR25","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/cancers11050686","volume":"11","author":"A Loras","year":"2019","unstructured":"Loras, A. et al. Integrative metabolomic and transcriptomic analysis for the study of bladder cancer. Cancers 11, 686 (2019).","journal-title":"Cancers"},{"key":"71211_CR26","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/bib\/bbv090","volume":"17","author":"R Cavill","year":"2016","unstructured":"Cavill, R., Jennen, D., Kleinjans, J. & Bried\u00e9, J. J. Transcriptomic and metabolomic data integration. Brief. Bioinform. 17, 891\u2013901 (2016).","journal-title":"Brief. Bioinform."},{"key":"71211_CR27","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: A flexible trimmer for illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"71211_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Langmead, B. & Salzberg, S. L. Hisat: A fast spliced aligner with low memory requirements. Nat. Methods 12, 357\u2013360 (2015).","journal-title":"Nat. Methods"},{"key":"71211_CR29","doi-asserted-by":"publisher","first-page":"R22","DOI":"10.1186\/gb-2011-12-3-r22","volume":"12","author":"A Roberts","year":"2011","unstructured":"Roberts, A., Trapnell, C., Donaghey, J., Rinn, J. L. & Pachter, L. Improving Rna-Seq expression estimates by correcting for fragment bias. Genome Biol. 12, R22 (2011).","journal-title":"Genome Biol."},{"key":"71211_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","volume":"28","author":"C Trapnell","year":"2010","unstructured":"Trapnell, C. et al. Transcript assembly and quantification by Rna-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511\u2013515 (2010).","journal-title":"Nat. Biotechnol."},{"key":"71211_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. Kegg: Kyoto encyclopedia of genes and genomes. Nucleic. Acids. Res. 28, 27\u201330 (2000).","journal-title":"Nucleic. Acids. Res."},{"key":"71211_CR32","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"71211_CR33","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"71211_CR34","doi-asserted-by":"publisher","first-page":"114922","DOI":"10.1016\/j.ab.2022.114922","volume":"658","author":"Y Liang","year":"2022","unstructured":"Liang, Y. et al. Dual isothermal amplification all-in-one approach for rapid and highly sensitive quantification of plasma circulating Mycn gene of neuroblastoma. Anal. Biochem. 658, 114922 (2022).","journal-title":"Anal. Biochem."},{"key":"71211_CR35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/PO.20.00181","volume":"5","author":"T O\u2019Donohue","year":"2021","unstructured":"O\u2019Donohue, T. et al. Differential impact of Alk mutations in neuroblastoma. Jco Precis. Oncol. 5, 492\u2013500 (2021).","journal-title":"Jco Precis. Oncol."},{"key":"71211_CR36","first-page":"3951","volume":"17","author":"L Bo","year":"2018","unstructured":"Bo, L. et al. Bioinformatics analysis of the Cdk2 functions in neuroblastoma. Mol. Med. Rep. 17, 3951\u20133959 (2018).","journal-title":"Mol. Med. Rep."},{"key":"71211_CR37","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3390\/biom11111567","volume":"11","author":"CJ Urso","year":"2021","unstructured":"Urso, C. J. & Zhou, H. Role of Cd36 in palmitic acid lipotoxicity in Neuro-2a neuroblastoma cells. Biomolecules 11, 1567 (2021).","journal-title":"Biomolecules"},{"key":"71211_CR38","doi-asserted-by":"publisher","first-page":"44340","DOI":"10.18632\/oncotarget.10041","volume":"7","author":"Z Zhen","year":"2016","unstructured":"Zhen, Z. et al. Involvement of Il-10 and Tgf-\u0392 in Hla-E-mediated neuroblastoma migration and invasion. Oncotarget 7, 44340\u201344349 (2016).","journal-title":"Oncotarget"},{"key":"71211_CR39","doi-asserted-by":"publisher","first-page":"e395","DOI":"10.1002\/ctm2.395","volume":"11","author":"L Miao","year":"2021","unstructured":"Miao, L. et al. Fabp4 deactivates Nf-\u039ab-Il1\u0391 pathway by ubiquitinating atpb in tumor-associated macrophages and promotes neuroblastoma progression. Clin. Transl. Med. 11, e395 (2021).","journal-title":"Clin. Transl. Med."},{"key":"71211_CR40","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3892\/mmr.2014.2100","volume":"9","author":"H Wang","year":"2014","unstructured":"Wang, H. et al. Unc5D regulates P53-dependent apoptosis in neuroblastoma cells. Mol. Med. Rep. 9, 2411\u20132416 (2014).","journal-title":"Mol. Med. Rep."},{"key":"71211_CR41","doi-asserted-by":"publisher","first-page":"25903","DOI":"10.18632\/oncotarget.25403","volume":"9","author":"M Ognibene","year":"2018","unstructured":"Ognibene, M. et al. Chl1 gene acts as a tumor suppressor in human neuroblastoma. Oncotarget 9, 25903\u201325921 (2018).","journal-title":"Oncotarget"},{"key":"71211_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1476-4598-12-70","volume":"12","author":"A Wilzen","year":"2013","unstructured":"Wilzen, A. et al. Erbb3 is a marker of a ganglioneuroblastoma\/ganglioneuroma-like expression profile in neuroblastic tumours. Mol. Cancer. 12, 70 (2013).","journal-title":"Mol. Cancer."},{"key":"71211_CR43","doi-asserted-by":"publisher","first-page":"731414","DOI":"10.3389\/fonc.2021.731414","volume":"11","author":"Y He","year":"2021","unstructured":"He, Y. et al. Integrated transcriptome analysis reveals the impact of photodynamic therapy on cerebrovascular endothelial cells. Front. Oncol. 11, 731414 (2021).","journal-title":"Front. Oncol."},{"key":"71211_CR44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ccr.2012.04.012","volume":"21","author":"FJ Swartling","year":"2012","unstructured":"Swartling, F. J. et al. Distinct neural stem cell populations give rise to disparate brain tumors in response to N-Myc. Cancer Cell. 21, 601\u2013613 (2012).","journal-title":"Cancer Cell."},{"key":"71211_CR45","first-page":"1853","volume":"54","author":"C Eberherr","year":"2019","unstructured":"Eberherr, C. et al. Targeting excessive Mycn expression using Mln8237 and Jq1 impairs the growth of hepatoblastoma cells. Int. J. Oncol. 54, 1853\u20131863 (2019).","journal-title":"Int. J. Oncol."},{"key":"71211_CR46","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1038\/s41467-022-31331-2","volume":"13","author":"L Tao","year":"2022","unstructured":"Tao, L. et al. Mycn-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma. Nat. Commun. 13, 3728 (2022).","journal-title":"Nat. Commun."},{"key":"71211_CR47","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1016\/j.celrep.2018.08.015","volume":"24","author":"D Ackerman","year":"2018","unstructured":"Ackerman, D. et al. Triglycerides promote lipid homeostasis during hypoxic stress by balancing fatty acid saturation. Cell Rep. 24, 2596\u20132605 (2018).","journal-title":"Cell Rep."},{"key":"71211_CR48","doi-asserted-by":"publisher","first-page":"881953","DOI":"10.3389\/fonc.2022.881953","volume":"12","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Multi-omics characterization of a glycerolipid metabolism-related gene enrichment score in colon cancer. Front. Oncol. 12, 881953 (2022).","journal-title":"Front. Oncol."},{"key":"71211_CR49","doi-asserted-by":"publisher","first-page":"712746","DOI":"10.3389\/fonc.2021.712746","volume":"11","author":"Z Xiong","year":"2021","unstructured":"Xiong, Z. et al. Exploration of lipid metabolism in gastric cancer: A novel prognostic genes expression profile. Front. Oncol. 11, 712746 (2021).","journal-title":"Front. Oncol."},{"key":"71211_CR50","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1159\/000512066","volume":"105","author":"P Chen","year":"2021","unstructured":"Chen, P., Chen, J., He, L., Du, C. & Wang, X. Identification of Circrna-Mirna-Mrna regulatory network in bladder cancer by integrated analysis. Urol. Int. 105, 705\u2013715 (2021).","journal-title":"Urol. Int."},{"key":"71211_CR51","doi-asserted-by":"publisher","first-page":"e00486","DOI":"10.14309\/ctg.0000000000000486","volume":"13","author":"J Vessby","year":"2022","unstructured":"Vessby, J. et al. Agpat1 as a novel colonic biomarker for discriminating between ulcerative colitis with and without primary sclerosing cholangitis. Clin. Transl. Gastroenterol. 13, e00486 (2022).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"71211_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00018-022-04289-z","volume":"79","author":"R La Grotta","year":"2022","unstructured":"La Grotta, R. et al. Anti-inflammatory effect of Sglt-2 inhibitors via uric acid and insulin. Cell. Mol. Life Sci. 79, 273 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"71211_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-022-01022-z","volume":"15","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Targeting purine metabolism in ovarian cancer. J. Ovarian Res. 15, 1\u201393 (2022).","journal-title":"J. Ovarian Res."},{"key":"71211_CR54","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.3390\/cells10102603","volume":"10","author":"H De Vitto","year":"2021","unstructured":"De Vitto, H., Arachchige, D., Richardson, B. & French, J. The intersection of purine and mitochondrial metabolism in cancer. Cells 10, 2603 (2021).","journal-title":"Cells"},{"key":"71211_CR55","doi-asserted-by":"publisher","first-page":"223","DOI":"10.22141\/2308-2097.53.4.2019.182401","volume":"53","author":"OV Syniachenko","year":"2019","unstructured":"Syniachenko, O. V., Aliiev, R. F., Iermolaieva, M. V. & Bondar, V. G. The changes in purine metabolism in gastric cancer. Gastroenterology 53, 223\u2013229 (2019).","journal-title":"Gastroenterology"},{"key":"71211_CR56","doi-asserted-by":"publisher","first-page":"110351","DOI":"10.1016\/j.ygeno.2022.110351","volume":"114","author":"X Chen","year":"2022","unstructured":"Chen, X. & Chen, J. Mir-10B-5P-mediated upregulation of Piezo1 predicts poor prognosis and links to purine metabolism in breast cancer. Genomics. 114, 110351 (2022).","journal-title":"Genomics."},{"issue":"Suppl 2","key":"71211_CR57","first-page":"1","volume":"109","author":"CHY Cheung","year":"2018","unstructured":"Cheung, C. H. Y. et al. \u201cAbstracts of the 77Th Annual Meeting of the Japanese Cancer Association; 2018 Sept 27\u201329; Osaka, Japan\u201d as Cancer Science, Supplement 2, Vol 109 (2018). Cancer Sci. 109(Suppl 2), 1\u20131444 (2018).","journal-title":"Cancer Sci."},{"key":"71211_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/pros.23243","volume":"77","author":"BVSK Chakravarthi","year":"2017","unstructured":"Chakravarthi, B. V. S. K. et al. Expression and role of Paics, a De Novo purine biosynthetic gene in prostate cancer. The Prostate 77, 10\u201321 (2017).","journal-title":"The Prostate"},{"key":"71211_CR59","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cmet.2013.11.004","volume":"18","author":"J Ding","year":"2013","unstructured":"Ding, J. et al. The histone H3 methyltransferase G9a epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. Cell Metab. 18, 896\u2013907 (2013).","journal-title":"Cell Metab."},{"key":"71211_CR60","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.celrep.2015.12.053","volume":"14","author":"E Zhao","year":"2016","unstructured":"Zhao, E. et al. Kdm4C and Atf4 cooperate in transcriptional control of amino acid metabolism. Cell Rep. 14, 506\u2013519 (2016).","journal-title":"Cell Rep."},{"key":"71211_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41389-020-0200-9","volume":"9","author":"E Zhao","year":"2020","unstructured":"Zhao, E., Hou, J. & Cui, H. Serine-glycine-one-carbon metabolism: Vulnerabilities in Mycn-amplified neuroblastoma. Oncogenesis N. Y. N. Y. 9, 14 (2020).","journal-title":"Oncogenesis N. Y. N. Y."},{"key":"71211_CR62","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1158\/0008-5472.CAN-18-3541","volume":"79","author":"Y Xia","year":"2019","unstructured":"Xia, Y. et al. Metabolic reprogramming by Mycn confers dependence on the serine-glycine-one-carbon biosynthetic pathway. Cancer Res. 79, 3837\u20133850 (2019).","journal-title":"Cancer Res."},{"key":"71211_CR63","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/1759-7714.13064","volume":"10","author":"L Liao","year":"2019","unstructured":"Liao, L. et al. Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients. Thorac. Cancer 10, 1203\u20131212 (2019).","journal-title":"Thorac. Cancer"},{"key":"71211_CR64","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nature14363","volume":"520","author":"D Kim","year":"2015","unstructured":"Kim, D. et al. Shmt2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Nature 520, 363\u2013367 (2015).","journal-title":"Nature"},{"key":"71211_CR65","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ymgme.2020.07.010","volume":"131","author":"J Leandro","year":"2020","unstructured":"Leandro, J. & Houten, S. M. The lysine degradation pathway: Subcellular compartmentalization and enzyme deficiencies. Mol. Genet. Metab. 131, 14\u201322 (2020).","journal-title":"Mol. Genet. Metab."},{"key":"71211_CR66","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12872-021-02209-w","volume":"21","author":"J Liu","year":"2021","unstructured":"Liu, J., Hu, J., Tan, L., Zhou, Q. & Wu, X. Abnormalities in lysine degradation are involved in early cardiomyocyte hypertrophy development in pressure-overloaded rats. BMC Cardiovasc. Disord. 21, 403 (2021).","journal-title":"BMC Cardiovasc. Disord."},{"key":"71211_CR67","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1038\/onc.2012.12","volume":"31","author":"C Sch\u00f6nherr","year":"2012","unstructured":"Sch\u00f6nherr, C. et al. Anaplastic lymphoma kinase (Alk) regulates initiation of transcription of Mycn in neuroblastoma cells. Oncogene 31, 5193\u20135200 (2012).","journal-title":"Oncogene"},{"key":"71211_CR68","doi-asserted-by":"publisher","first-page":"317","DOI":"10.5588\/pha.13.0067","volume":"3","author":"W Htike","year":"2013","unstructured":"Htike, W., Islam, M. A., Hasan, M. T., Ferdous, S. & Rifat, M. Factors associated with treatment delay among tuberculosis patients referred from a tertiary hospital in Dhaka City: A cross-sectional study. Public Health Action 3, 317\u2013322 (2013).","journal-title":"Public Health Action"},{"key":"71211_CR69","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1523\/JNEUROSCI.0183-16.2016","volume":"36","author":"M Kramer","year":"2016","unstructured":"Kramer, M., Ribeiro, D., Arsenian-Henriksson, M., Deller, T. & Rohrer, H. Proliferation and survival of embryonic sympathetic neuroblasts by Mycn and activated Alk signaling. J. Neurosci. 36, 10425\u201310439 (2016).","journal-title":"J. Neurosci."},{"key":"71211_CR70","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1038\/onc.2012.12","volume":"31","author":"C Sch\u00f6nherr","year":"2012","unstructured":"Sch\u00f6nherr, C. et al. Anaplastic lymphoma kinase (Alk) regulates initiation of transcription of Mycn in neuroblastoma cells. Oncogene. 31, 5193\u20135200 (2012).","journal-title":"Oncogene."},{"key":"71211_CR71","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1038\/srep03450","volume":"3","author":"MK Hasan","year":"2013","unstructured":"Hasan, M. K. et al. Alk is a Mycn target gene and regulates cell migration and invasion in neuroblastoma. Sci. Rep. 3, 3450 (2013).","journal-title":"Sci. Rep."},{"key":"71211_CR72","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1002\/cbin.11442","volume":"44","author":"XH Liang","year":"2020","unstructured":"Liang, X. H. et al. Mapre1 promotes cell cycle progression of hepatocellular carcinoma cells by interacting with Cdk2. Cell Biol. Int. 44, 2326\u20132333 (2020).","journal-title":"Cell Biol. Int."},{"key":"71211_CR73","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.4161\/cc.24091","volume":"12","author":"S Gogolin","year":"2014","unstructured":"Gogolin, S. et al. Cdk4 inhibition restores G1-S arrest in Mycn-amplified neuroblastoma cells in the context of doxorubicin-induced Dna damage. Cell Cycle 12, 1091\u20131104 (2014).","journal-title":"Cell Cycle"},{"key":"71211_CR74","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3892\/ijo.2012.1684","volume":"42","author":"M Nozato","year":"2013","unstructured":"Nozato, M., Kaneko, S., Nakagawara, A. & Komuro, H. Epithelial-mesenchymal transition-related gene expression as a new prognostic marker for neuroblastoma. Int. J. Oncol. 42, 134\u2013140 (2013).","journal-title":"Int. J. Oncol."},{"key":"71211_CR75","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1056\/NEJMcibr1806782","volume":"379","author":"SG DuBois","year":"2018","unstructured":"DuBois, S. G. & Park, J. R. Neuroblastoma and histone demethylation. N. Engl. J. Med. 379, 1476\u20131477 (2018).","journal-title":"N. Engl. J. Med."},{"key":"71211_CR76","doi-asserted-by":"publisher","first-page":"578770","DOI":"10.3389\/fcell.2020.578770","volume":"8","author":"M Phimmachanh","year":"2020","unstructured":"Phimmachanh, M., Han, J. Z. R., Donnell, Y. E. I., Latham, S. L. & Croucher, D. R. Histone deacetylases and histone deacetylase inhibitors in neuroblastoma. Front. Cell. Dev. Biol. 8, 578770 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"key":"71211_CR77","doi-asserted-by":"publisher","first-page":"e004834","DOI":"10.1136\/jitc-2022-004834","volume":"10","author":"TJ Aiken","year":"2022","unstructured":"Aiken, T. J. et al. Mechanism of effective combination radio-immunotherapy against 9464D-Gd2, an immunologically cold murine neuroblastoma. J. Immunother. Cancer 10, e004834 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"71211_CR78","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2020.11.014","volume":"144","author":"J Wienke","year":"2021","unstructured":"Wienke, J. et al. The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology. Eur. J. Cancer 144, 123\u2013150 (2021).","journal-title":"Eur. J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71211-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71211-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71211-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T05:04:17Z","timestamp":1724994257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71211-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71211"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71211-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"8 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was signed by children or their parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"20155"}}